Evidence map›Paper›PMID 34100437›Full record

ArticleNeural regeneration research2022

The new wave of p75 neurotrophin receptor targeted therapies.

Amanda M Crooks, Rick B Meeker

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neural regeneration research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Nerve Growth Factor and Autoimmune Diseases.Current issues in molecular biology · 2023
    Review
  3. Article
  4. The Nerve Growth Factor Receptor (NGFR/p75International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amanda M CrooksUNC School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Rick B MeekerDepartment of Neurology, University of North Carolina, Chapel Hill, NC, USA.
University of North Carolina at Chapel Hill · US

Funding

Neural network dysfunction in early HIV neuropathogenesisR01NS108808 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MEEKER, RICK B · 2018 to 2022
$1.9M
Neurotrophin Protection in HIV and AgingR01NS083164 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MEEKER, RICK B · 2013 to 2016
$1.1M
NINDS NIH HHS R01 NS083164NINDS NIH HHS R01 NS108808
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34100437
PMCPMC8451542
OpenAlexW3173043730

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.